Skip to main content

Table 1 Patients' baseline and disease characteristics

From: Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Characteristics

Patients (n = 61)

Median age, years (range)

60 (31-80)

Gender, n (%):

 

   Male

39 (64)

   Female

22 (36)

WHO performance status, n (%)

 

   0

52 (85)

   1

9 (15)

TN clinical stage, n (%)

 

   T3N0

12 (19.7)

   T2N1

1 (1.7)

   T3N1

19 (31.1)

   T2N2

2 (3.3)

   T3N2

22 (36.1)

   T4N2

5 (8.2)

Median clinical tumour size per MRI, cm (range)

6 (1-12)

Median tumour distance from anal verge, cm (range)

6 (0-11)

Type of surgerya, n (%)

 

   Low anterior resection

35 (57.4)

   Coloanal reconstruction

10 (16.4)

   Abdominoperineal resection

14 (23.0)

   Pelvic exenteration

2 (3.3)

  1. aAs planned before the start of preoperative chemoradiotherapy.
  2. MRI, magnetic nuclear imaging; N, node; T, tumour; WHO, World Health Organization.